Voliotis Dimitris

CIK 00018079101 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001807910

Recent Transactions

21 trades

Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-02-14$50.75/sh−67→ 15,978 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-02-14$50.16/sh−534→ 16,045 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2022-02-10+24,234→ 24,234 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-02-10+10,329→ 16,579 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-20$18.00/sh+10,000→ 16,250 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-20$61.21/sh−1,657→ 6,250 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-20$60.52/sh−8,343→ 7,907 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option
2022-01-20−10,000→ 124,949 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-19$18.00/sh+10,000→ 16,250 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option
2022-01-19−10,000→ 134,949 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-19$62.24/sh−555→ 6,250 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-19$60.55/sh−7,889→ 8,361 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-19$61.51/sh−1,556→ 6,805 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-18$61.70/sh−3,409→ 12,841 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-18$63.48/sh−1,997→ 7,550 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-18$18.00/sh+10,000→ 16,250 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-18$64.66/sh−1,300→ 6,250 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option
2022-01-18−10,000→ 144,949 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-18$62.34/sh−3,294→ 9,547 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2021-02-11+6,250→ 6,250 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2021-02-11+18,750→ 18,750 total

Companies

Zentalis Pharmaceuticals, Inc.
SVP, Clinical Development
$ZNTL

Recent Filings

Address

C/O ZENTALIS PHARMACEUTICALS, INC. 530 SEVENTH AVENUE, SUITE 2201

NEW YORK, NY, 10018

View on SEC.gov